In‐Ho Song

3.8k total citations · 1 hit paper
84 papers, 2.7k citations indexed

About

In‐Ho Song is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, In‐Ho Song has authored 84 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Rheumatology, 26 papers in Hematology and 26 papers in Immunology. Recurrent topics in In‐Ho Song's work include Spondyloarthritis Studies and Treatments (58 papers), Rheumatoid Arthritis Research and Therapies (49 papers) and Autoimmune and Inflammatory Disorders Research (26 papers). In‐Ho Song is often cited by papers focused on Spondyloarthritis Studies and Treatments (58 papers), Rheumatoid Arthritis Research and Therapies (49 papers) and Autoimmune and Inflammatory Disorders Research (26 papers). In‐Ho Song collaborates with scholars based in United States, Germany and Belgium. In‐Ho Song's co-authors include Joachim Sieper, Martín Rudwaleit, Denis Poddubnyy, Hildrun Haibel, Frank Buttgereit, Joachim Listing, Kay‐Geert Hermann, Yihan Li, Anja Weiß and Andrew J.K. Östör and has published in prestigious journals such as The Lancet, Brain and Clinical Infectious Diseases.

In The Last Decade

In‐Ho Song

77 papers receiving 2.6k citations

Hit Papers

Upadacitinib Versus Placebo or Adalimumab in Patients Wit... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
In‐Ho Song United States 28 2.0k 1.0k 777 278 228 84 2.7k
Dorothy McCabe United States 17 1.3k 0.7× 896 0.9× 706 0.9× 70 0.3× 541 2.4× 37 2.5k
Antonio Spadaro Italy 28 1.3k 0.7× 925 0.9× 504 0.6× 118 0.4× 201 0.9× 127 2.1k
Joseph A. Markenson United States 20 2.2k 1.1× 587 0.6× 1.0k 1.3× 45 0.2× 192 0.8× 42 3.0k
Paola Conigliaro Italy 27 1.0k 0.5× 892 0.9× 389 0.5× 29 0.1× 363 1.6× 97 2.0k
Jan Leipe Germany 18 639 0.3× 1.1k 1.1× 294 0.4× 65 0.2× 507 2.2× 88 2.4k
Paola Triggianese Italy 26 888 0.5× 827 0.8× 359 0.5× 27 0.1× 308 1.4× 91 1.9k
Debra Zack United States 24 972 0.5× 567 0.6× 212 0.3× 135 0.5× 561 2.5× 35 1.7k
Seung Cheol Shim South Korea 24 586 0.3× 591 0.6× 159 0.2× 25 0.1× 386 1.7× 100 1.5k
E.‐M. Lemmel Germany 21 451 0.2× 388 0.4× 209 0.3× 64 0.2× 181 0.8× 56 1.2k
Mary Canavan Ireland 22 502 0.3× 638 0.6× 224 0.3× 23 0.1× 495 2.2× 32 1.5k

Countries citing papers authored by In‐Ho Song

Since Specialization
Citations

This map shows the geographic impact of In‐Ho Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In‐Ho Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In‐Ho Song more than expected).

Fields of papers citing papers by In‐Ho Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In‐Ho Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In‐Ho Song. The network helps show where In‐Ho Song may publish in the future.

Co-authorship network of co-authors of In‐Ho Song

This figure shows the co-authorship network connecting the top 25 collaborators of In‐Ho Song. A scholar is included among the top collaborators of In‐Ho Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In‐Ho Song. In‐Ho Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Bosch, Filip Van den, Atul Deodhar, Denis Poddubnyy, et al.. (2024). Upadacitinib in Active Non‐radiographic Axial Spondyloarthritis: 1‐Year Data From a Double‐Blind, Randomized, Placebo‐Controlled, Phase 3 Trial. ACR Open Rheumatology. 6(8). 470–480. 3 indexed citations
5.
Navarro‐Compán, Victoria, Xenofon Baraliakos, Marina Magrey, et al.. (2023). Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and Therapy. 10(3). 679–691. 8 indexed citations
6.
Baraliakos, Xenofon, Désirée van der Heijde, Joachim Sieper, et al.. (2023). Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study. Arthritis Research & Therapy. 25(1). 172–172. 12 indexed citations
7.
Bosch, Filip Van den, Atul Deodhar, Denis Poddubnyy, et al.. (2023). POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases. 82. 361–362. 2 indexed citations
8.
Heijde, Désirée van der, Xenofon Baraliakos, Joachim Sieper, et al.. (2022). Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. Annals of the Rheumatic Diseases. 81(11). 1515–1523. 79 indexed citations
9.
Heijde, Désirée van der, Atul Deodhar, Walter P. Maksymowych, et al.. (2022). Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension. RMD Open. 8(2). e002280–e002280. 32 indexed citations
10.
Coates, Laura C., Sonya Abraham, William Tillett, et al.. (2020). Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab. Arthritis Care & Research. 74(2). 259–267. 4 indexed citations
11.
Turina, M., Sofía Ramiro, Dominique Baeten, et al.. (2015). A psychometric analysis of outcome measures in peripheral spondyloarthritis. Annals of the Rheumatic Diseases. 75(7). 1302–1307. 21 indexed citations
12.
Song, In‐Ho, et al.. (2014). Economic Dynamism of Korea: With a Focus on the Comparison with Japan. 3 indexed citations
13.
Krohn, Michaela, Joachim Sieper, In‐Ho Song, et al.. (2014). Erosions and Fatty Lesions of Sacroiliac Joints in Patients with Axial Spondyloarthritis: Evaluation of Different MRI Techniques and Two Scoring Methods. The Journal of Rheumatology. 41(3). 473–480. 28 indexed citations
14.
Poddubnyy, Denis, I. Z. Gaydukova, Kay‐Geert Hermann, et al.. (2013). Magnetic Resonance Imaging Compared to Conventional Radiographs for Detection of Chronic Structural Changes in Sacroiliac Joints in Axial Spondyloarthritis. The Journal of Rheumatology. 40(9). 1557–1565. 52 indexed citations
15.
Song, In‐Ho, Christian E. Althoff, Hildrun Haibel, et al.. (2012). Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial. Annals of the Rheumatic Diseases. 71(7). 1212–1215. 68 indexed citations
16.
Song, In‐Ho & Denis Poddubnyy. (2011). New treatment targets in ankylosing spondylitis and other spondyloarthritides. Current Opinion in Rheumatology. 23(4). 346–351. 12 indexed citations
17.
Song, In‐Ho, H. Brandt, Martín Rudwaleit, & Joachim Sieper. (2010). Limited Diagnostic Value of Unilateral Sacroiliitis in Scintigraphy in Assessing Axial Spondyloarthritis. The Journal of Rheumatology. 37(6). 1200–1202. 18 indexed citations
18.
Song, In‐Ho, Denis Poddubnyy, Martín Rudwaleit, & Joachim Sieper. (2008). Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs. Arthritis & Rheumatism. 58(4). 929–938. 104 indexed citations
19.
Kwon, Yong-Sham, et al.. (2004). Recent Progresses for the Variety Classification and Denomination of Oriental Melon and Melon (Cucumis melo L.). 22(4). 515–522. 6 indexed citations
20.
Song, In‐Ho, et al.. (2003). Application of amplified fragment length polymorphism (AFLP) analysis for DUS test in pepper cultivars. Korean Journal of Breeding Science. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026